VANI

$1.05-3.67%visit website

Vivani Medical, Inc.

Market Cap

$95M

Live price × SEC shares (Aug 13, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

2.53

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

5.0

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	4,519	4,630	4,390	4,456	17,995
Total operating expenses	6,725	6,810	6,817	6,874	27,226
Operating income	(6,725)	(6,810)	(6,817)	(6,874)	(27,226)
Net income	(6,530)	(6,633)	(6,780)	(6,370)	(26,313)
EPS (basic) ($)	(0.11)		(0.08)	(0.07)	(0.36)
EPS (diluted) ($)	(0.11)		(0.08)	(0.07)	(0.36)
Weighted avg. shares (basic)	59,711		81,269	87,090
Weighted avg. shares (diluted)	59,711		81,269	87,090

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 46 more quarters, back to Mar 2014, with Tormere Pro.

Corporate Events (8-K)

14 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 30, 2026 accepted 4:30 PM ET	7.01Reg FD disclosure	Document SEC ↗
Oct 29, 2026 accepted 7:30 AM ET	7.01Reg FD disclosure	Document SEC ↗
Sep 16, 2026 accepted 4:15 PM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 17, 2026 accepted 8:00 AM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 13, 2026 accepted 4:31 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Aug 6, 2026 accepted 8:15 AM ET	7.01Reg FD disclosure	Document SEC ↗
Jul 16, 2026 accepted 8:30 AM ET	7.01Reg FD disclosure	Document SEC ↗
Jul 7, 2026 accepted 7:46 AM ET	1.01Material agreement8.01Other events	Document SEC ↗
Jun 30, 2026 accepted 8:03 AM ET	5.02Officer / director change5.07Shareholder vote8.01Other events	Document SEC ↗
Jun 4, 2026 accepted 7:30 AM ET	7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

63%

W/W +33.1pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-07-15	2026-07-16	Williams Gregg	Director	Purchase	793.6K	$1.26	$1000K	36.91M	View
2026-06-15	2026-06-16	Williams Gregg	Director	Purchase	1.59M	$1.26	$2.00M	36.12M	View
2026-05-15	2026-05-19	Williams Gregg	Director	Purchase	1.59M	$1.26	$2.00M	34.53M	View
2026-04-15	2026-04-16	Williams Gregg	Director	Purchase	1.59M	$1.26	$2.00M	32.94M	View
2026-03-15	2026-03-16	Williams Gregg	Director	Purchase	1.58M	$1.07	$1.68M	31.36M	View

1–5 of 6

1 / 2

Recent News

Vani Commercials FY26 Net Profit Rises 38% to ₹36 Lakh

scanx.trade · 2026-11-01

Vivani Medical merger with ClearOne awaits final regulatory approval By Investing.com

Investing.com Nigeria · 2026-10-30

Vivani Medical's Cortigent-ClearOne Merger Delayed Pending Final Regulatory Approval

Kalkine Media · 2026-10-30

Vivani Medical (NASDAQ:VANI) Shares Down 6% - What's Next?

MarketBeat · 2026-10-23

A director gifts 20,000 Vivani Medical (VANI) shares to a non-affiliated entity.

Stock Titan · 2026-10-19

Vivani Medical Announces Participation in Upcoming Investor Conferences

Yahoo · 2026-10-12

The CEO of a company developing long-lasting medicine implants will present in New York Oct. 15.

Stock Titan · 2026-10-12

Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Yahoo Finance · 2026-08-06

Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal

Yahoo Finance · 2026-07-15

Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026

Yahoo Finance · 2026-07-14

Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant

Yahoo Finance · 2026-07-08

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Yahoo Finance · 2026-07-07

Vivani in pact with Novo to study Wegovy implant (NVO:NYSE)

Seeking Alpha · 2026-07-07

Vivani strikes reverse-merger agreement with ClearOne for BCI business

Yahoo Finance · 2026-07-03

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

Yahoo Finance · 2026-06-25

Informational purposes only, not investment advice.

VANI

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Vivani Medical, Inc. (VANI)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-07-15	Williams Gregg	P	793,650	$999,999
2026-06-15	Williams Gregg	P	1,587,301	$2M
2026-05-15	Williams Gregg	P	1,587,301	$2M
2026-04-15	Williams Gregg	P	1,587,301	$2M
2026-03-15	Williams Gregg	P	264,551	$333,334.26